New Approaches to the Use of Endocrine Therapy in Breast Cancer

  • R. C. Coombes
  • J. Williams
  • A. Brodie
  • T. J. Powles
  • A. M. Neville
Part of the Developments in Oncology book series (DION, volume 23)


Endocrine therapy has become more important in recent years in the management of breast cancer because of its lack of toxicity and consequent excellent remissions that it can sometimes provide. Furthermore, the oestrogen receptor assay can, to a certain extent, predict which patients will respond to therapy, thus reinforcing the need for a reappraisal of our strategy in selecting agents for clinical use and in defining their mechanism of action. Improved knowledge of mechanisms should lead to rational combinations which could lead to increased response rates and prolonged survival for patients with breast cancer.


Breast Cancer Endocrine Therapy Mammary Tumour Advanced Breast Cancer Medroxyprogesterone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Williams JC, Gusterson B, Humphreys J, Monaghan P, Coombes RC, Rudland P, Neville AM: N-Nitrosomethylurea-induced rat mammary tumours - hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst (66): 147–155, 1981.PubMedGoogle Scholar
  2. 2.
    Williams JC, Singh D, Brodie A, Coombes RC: Endocrine agents and their effect in rats bearing NMU-induced mammary tumours. (In preparation).Google Scholar
  3. 3.
    Brodie A: Personal Communication.Google Scholar
  4. 4.
    Harris AL, Powles TJ, Smith IE, Coombes RC, Ford HT, Gazet J-C, Harmer CL, Morgan M, White H, Parsons CA, McKinna JA: Aminoglutethimide for the treatment of advanced postmenopausal breast cancer. Eur J Cancer Clin Oncol (19): 11–17, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Coombes RC, Perez D, Gazet J-C, Ford HT, Powles TJ: Danazol treatment for advanced breast cancer. Cancer Chemother Pharmacol (10): 194–195, 1983.PubMedGoogle Scholar
  6. 6.
    Coombes RC, Powles TJ, Muindi J, Hunt J, Ward M, Perez D, Neville AM: Trilostane therapy for advanced breast cancer. In Press.Google Scholar
  7. 7.
    Powles TJ, Gordon C, Coombes RC: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone. Cancer Res (42) (Suppl) 3458S–3460S, 1982.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • R. C. Coombes
  • J. Williams
  • A. Brodie
  • T. J. Powles
  • A. M. Neville

There are no affiliations available

Personalised recommendations